06998.HK 股價走勢圖
EDDING GENOR (06998.HK)
Edding Genor Group Holdings Limited
HK$2.75
-2.82%
$-0.08
休市： May 12, 16:00:00 HKT
返回
Edding Genor Group Holdings Limited (06998.HK)
關鍵數據
前收市價
$2.75
開盤價
$2.83
當日範圍
$2.72 - $2.84
52週區間
$2.25 - $3.64
交易量
1.2M
平均成交量
2.0M
股息收益率
--
每股盈餘 (TTM)
0.07
市值
$5.5B
什麼是 EDDING GENOR？
Genor Biopharma Holdings Ltd. engages in the development and commercialization of oncology and autoimmune drugs. The company is headquartered in Shanghai, Shanghai and currently employs 17 full-time employees. The company went IPO on 2020-10-07. The Company’s main business is engaged in the discovery, development and commercialization of biopharmaceutical products for human use. The Company’s product pipelines include Lerociclib (GB491), GB261, GB263T, Infliximab (GB242), Coprelotamab (GB221), GB223, Rituximab (GB241), Vancocin, Ceclor and other products, covering disease fields such as breast cancer, lung cancer, gastrointestinal tumors, and blood tumors. The firm mainly conducts its business in the domestic market.
